International Myeloma Foundation Responds to ICER Report

The International Myeloma Foundation (IMF) recently spoke out against the Institute for Clinical and Economic Review’s (ICER) report on the value of myeloma drugs. Find out what IMF had to say here. (Source: Journal of Clinical Pathways, 5/26/16)

You might also be interested in:

Patient Drug Costs Increased as Health Plans Promote… 08/07/2020
Syapse and FDA Leverage Real-World Data to Study Impact of… 10/05/2020
What Are The Recent Top 4 Innovative Consolidations and… 08/26/2020
ICER Publishes Final Evidence Report on Digital Therapeutics… 12/11/2020
ICER Releases Draft Evidence Report for Several Multiple… 02/15/2021
Tufts Medical Center and National Health Council Report New… 05/25/2021
The Journal of Clinical Pathways Issues Call for Papers 04/16/2021